Connection

Paul Gurbel to Anticoagulants

Back to Details
This is a "connection" page, showing publications Paul Gurbel has written about Anticoagulants.
Paul Gurbel
Connection Strength
0.668
Anticoagulants
  1. Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population. J Thromb Thrombolysis. 2021 May; 51(4):902-904.
    View in: PubMed
    Score: 0.195
  2. Antithrombotic Strategies and Device Thrombosis. Cardiol Clin. 2018 Nov; 36(4):541-550.
    View in: PubMed
    Score: 0.163
  3. Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system. J Thromb Thrombolysis. 2017 May; 43(4):437-445.
    View in: PubMed
    Score: 0.149
  4. In search for an optimal antithrombotic regimen in patients with atrial fibrillation undergoing stenting. Kardiol Pol. 2019 Sep 23; 77(9):817-819.
    View in: PubMed
    Score: 0.044
  5. Rivaroxaban in Stable Cardiovascular Disease. N Engl J Med. 2018 01 25; 378(4):396.
    View in: PubMed
    Score: 0.039
  6. Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians? Curr Vasc Pharmacol. 2018; 16(5):459-476.
    View in: PubMed
    Score: 0.039
  7. Thromboembolism after WATCHMANTM in a clopidogrel non-responder: A case for concern? Catheter Cardiovasc Interv. 2018 07; 92(1):200-202.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.